- Home
- LVRO vs ORIC Comparison
LVRO vs ORIC Comparison
Compare LVRO & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVRO
- ORIC
- Stock Information
- Founded
- LVRO 2017
- ORIC 2014
- Country
- LVRO Brazil
- ORIC United States
- Employees
- LVRO N/A
- ORIC N/A
- Industry
- LVRO Blank Checks
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- LVRO Finance
- ORIC Health Care
- Exchange
- LVRO Nasdaq
- ORIC Nasdaq
- Market Cap
- LVRO 279.6M
- ORIC 362.9M
- IPO Year
- LVRO N/A
- ORIC 2020
- Fundamental
- Price
- LVRO $2.04
- ORIC $10.65
- Analyst Decision
- LVRO Sell
- ORIC Strong Buy
- Analyst Count
- LVRO 3
- ORIC 8
- Target Price
- LVRO $1.88
- ORIC $18.83
- AVG Volume (30 Days)
- LVRO 7.1K
- ORIC 1.2M
- Earning Date
- LVRO 07-11-2025
- ORIC 08-11-2025
- Dividend Yield
- LVRO N/A
- ORIC N/A
- EPS Growth
- LVRO N/A
- ORIC N/A
- EPS
- LVRO N/A
- ORIC N/A
- Revenue
- LVRO $1,667,345,189.00
- ORIC N/A
- Revenue This Year
- LVRO N/A
- ORIC N/A
- Revenue Next Year
- LVRO $12.46
- ORIC N/A
- P/E Ratio
- LVRO N/A
- ORIC N/A
- Revenue Growth
- LVRO N/A
- ORIC N/A
- 52 Week Low
- LVRO $1.90
- ORIC $3.90
- 52 Week High
- LVRO $5.69
- ORIC $14.67
- Technical
- Relative Strength Index (RSI)
- LVRO 39.91
- ORIC 70.08
- Support Level
- LVRO $1.90
- ORIC $9.80
- Resistance Level
- LVRO $2.28
- ORIC $10.99
- Average True Range (ATR)
- LVRO 0.19
- ORIC 0.66
- MACD
- LVRO -0.02
- ORIC -0.05
- Stochastic Oscillator
- LVRO 15.38
- ORIC 76.92
About LVRO Lavoro Limited
Lavoro Ltd operates in the agricultural inputs retail market, with operations spread across Brazil and Colombia, and an emergent agricultural input trading company in Uruguay. The reportable segments of the company include the Brazil Ag Retail, which comprises companies dedicated to the distribution of agricultural inputs such as crop protection, seeds, fertilizers and specialty products, in Brazil; Latam Ag Retail, which includes companies dedicated to the distribution of agricultural inputs outside Brazil (predominantly in Colombia); and the Crop Care. A substantial part of the company's overall revenue is generated from its Brazil Ag Retail segment.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.